Autres langues Zai Lab Limited

Actions

ZLAB

US98887Q1040

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
24,33 ^USD	-4,59 %		-2,60 %	+37,93 %

02/10	Les actions asiatiques négociées aux États-Unis via des certificats américains de dépôt progressent vendredi ; semaine stable	MT
29/09	Zai Lab Limited présentera les premières données mondiales d’un essai clinique évaluant le zocilurtatug pelitecan en première ligne dans le cancer bronchique à petites cellules de stade étendu	CI

Autres langues

02/10	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Flat
29/09	Zai Lab Limited To Present First Global Data From Clinical Trial Evaluating Zocilurtatug Pelitecan As First-Line Treatment For Extensive-Stage Small Cell Lung Cancer
29/09	Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
24/09	Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
04/09	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading
02/09	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
31/08	Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
28/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 2% for Week
26/08	Zai Lab's Net Loss Widens 14% in H1, Revenue Drops 6%
25/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
19/08	Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
17/08	Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
17/08	Zai Lab Limited and Argenx Announces Positive Topline Results From Phase 3 Alkivia Trial Of Efgartigimod In Autoimmune Myositis
13/08	Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading
11/08	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
07/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; End Week Up 2%
06/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
06/08	Zai Lab Shares Rise After Q2 Beat
06/08	Zai Lab Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Earnings Flash (ZLAB) Zai Lab Limited Reports Q2 Revenue $106.3M, vs. FactSet Est of $103.9M
06/08	Earnings Flash (ZLAB) Zai Lab Limited Reports Q2 Loss of $0.46 per ADS, vs. FactSet Est of $-0.68
06/08	Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates
03/08	Zai Lab Receives FDA Orphan Drug Designation for Zocilurtatug Pelitecan in Neuroendocrine Carcinomas
03/08	U.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs)
29/07	Asian Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading